Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TENX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 28 days ago
Red flags: 2
111 filers reported a long position in TENX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $57.4M | 3.9M | +1,122.1% |
| Vivo Capital, LLC | $36.4M | 2.5M | +1,100% |
| BlackRock, Inc. | $25.1M | 1.7M | +10,078.4% |
| PERCEPTIVE ADVISORS LLC | $24.7M | 1.7M | +17.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.7M | 1.1M | +335.5% |
| MILLENNIUM MANAGEMENT LLC | $12.7M | 876.2K | +64.1% |
| Ikarian Capital, LLC | $11.5M | 787.6K | -22.6% |
| Candriam S.C.A. | $10.9M | 749.6K | New |
| CITADEL ADVISORS LLC | $10.6M | 728.6K | +377.7% |
| RTW INVESTMENTS, LP | $10.1M | 696.6K | +88.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.